MY126346A - Valaciclovir tablets containing colloidal silicon dioxide - Google Patents

Valaciclovir tablets containing colloidal silicon dioxide

Info

Publication number
MY126346A
MY126346A MYPI96000222A MYPI9600222A MY126346A MY 126346 A MY126346 A MY 126346A MY PI96000222 A MYPI96000222 A MY PI96000222A MY PI9600222 A MYPI9600222 A MY PI9600222A MY 126346 A MY126346 A MY 126346A
Authority
MY
Malaysia
Prior art keywords
silicon dioxide
colloidal silicon
tablets containing
containing colloidal
valaciclovir
Prior art date
Application number
MYPI96000222A
Other languages
English (en)
Inventor
Barry Howard Carter
Llyod Gary Tillman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY126346(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MY126346A publication Critical patent/MY126346A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MYPI96000222A 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide MY126346A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet

Publications (1)

Publication Number Publication Date
MY126346A true MY126346A (en) 2006-09-29

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI96000222A MY126346A (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide

Country Status (38)

Country Link
US (1) US5879706A (en:Method)
EP (1) EP0806943B1 (en:Method)
JP (1) JP3350055B2 (en:Method)
KR (1) KR100412298B1 (en:Method)
CN (2) CN1313081C (en:Method)
AP (1) AP666A (en:Method)
AT (1) ATE190483T1 (en:Method)
AU (1) AU710823B2 (en:Method)
BG (1) BG63187B1 (en:Method)
BR (1) BR9606769A (en:Method)
CA (1) CA2210891C (en:Method)
CY (1) CY2182B1 (en:Method)
CZ (1) CZ296514B6 (en:Method)
DE (1) DE69607146T2 (en:Method)
DK (1) DK0806943T3 (en:Method)
EA (1) EA000276B1 (en:Method)
EE (1) EE03336B1 (en:Method)
ES (1) ES2145425T3 (en:Method)
FI (1) FI119722B (en:Method)
GB (1) GB9501127D0 (en:Method)
GE (1) GEP20022752B (en:Method)
GR (1) GR3033677T3 (en:Method)
HU (1) HU226131B1 (en:Method)
IL (1) IL116830A (en:Method)
IN (1) IN181318B (en:Method)
MY (1) MY126346A (en:Method)
NO (1) NO311488B1 (en:Method)
NZ (1) NZ298846A (en:Method)
OA (1) OA10500A (en:Method)
PL (1) PL185307B1 (en:Method)
PT (1) PT806943E (en:Method)
RO (1) RO118175B1 (en:Method)
SK (1) SK282030B6 (en:Method)
TR (1) TR199700657T1 (en:Method)
UA (1) UA68325C2 (en:Method)
UY (2) UY25774A1 (en:Method)
WO (1) WO1996022082A1 (en:Method)
ZA (1) ZA96448B (en:Method)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
ES2212667T3 (es) * 1998-12-18 2004-07-16 Abbott Laboratories Formulacion de liberacion controlada con divalproex sodico.
GB0010446D0 (en) 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
PL366453A1 (en) * 2001-05-01 2005-02-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US20040197396A1 (en) * 2001-11-05 2004-10-07 Fain Helen S Anhydrous crystal form of valaciclovir hydrochloride
JP2005508993A (ja) * 2001-11-14 2005-04-07 テバ ファーマシューティカル インダストリーズ リミティド バラシクロビルの合成及び精製
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1517678A2 (en) * 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
ATE335743T1 (de) * 2002-10-16 2006-09-15 Teva Pharma Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochlorid
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2003232719A1 (en) * 2003-05-30 2005-01-21 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Novel crystalline forms of valacyclovir hydrochloride
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
DK3395338T3 (da) 2003-09-12 2019-07-22 Amgen Inc Hurtigt opløsende formulering af cinacalcet-hcl
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1541133B1 (en) * 2003-12-09 2005-08-10 Helm AG Pharmaceutical formulation of valaciclovir
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
WO2006094626A1 (en) 2005-03-07 2006-09-14 Bayer Healthcare Ag Pharmaceutical composition comprising an omega- carboxyaryl substituted diphenyl urea for the treatment of cancer
WO2006127217A2 (en) * 2005-05-25 2006-11-30 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
US20090312439A1 (en) * 2006-05-10 2009-12-17 Ralph Hofmann Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
ATE481089T1 (de) * 2006-05-31 2010-10-15 Vertex Pharma Orale formulierungen mit kontrollierter freisetzung eines interleukin-1-beta-converting- enzyme inhibitors
US20090291136A1 (en) * 2006-07-11 2009-11-26 Lek Pharmaceuticals D.D. Multiple Unit Tablets
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US8513261B2 (en) * 2009-03-13 2013-08-20 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
EP4157221A4 (en) * 2020-06-01 2024-07-24 Shilpa Medicare Limited RAPIDLY DISPERSABLE PHARMACEUTICAL COMPOSITION CONTAINING CAPECITABINE
AR124180A1 (es) * 2020-12-01 2023-02-22 Lg Chemical Ltd Formulación compuesta para administración oral que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxílico y un proceso para su preparación
AU2023332020A1 (en) * 2022-08-31 2025-04-17 Astrazeneca Ab Pharmaceutical formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
IL100796A (en) * 1991-01-30 1998-09-24 Wellcome Found Water-dispersible tablets containing aciclovir or lamotrigine
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
PL185307B1 (pl) 2003-04-30
EA199700123A1 (ru) 1997-12-30
UA68325C2 (en) 2004-08-16
NO973327L (no) 1997-09-16
NZ298846A (en) 1998-06-26
BG63187B1 (bg) 2001-06-29
AP666A (en) 1998-08-24
KR100412298B1 (ko) 2004-04-21
SK96497A3 (en) 1998-01-14
RO118175B1 (ro) 2003-03-28
HU226131B1 (en) 2008-05-28
KR19980701524A (ko) 1998-05-15
IL116830A (en) 2000-02-29
SK282030B6 (sk) 2001-10-08
HK1002851A1 (en) 1998-09-25
PL321361A1 (en) 1997-12-08
CY2182B1 (en) 2002-08-23
GR3033677T3 (en) 2000-10-31
IN181318B (en:Method) 1998-05-09
HUP9801872A3 (en) 2001-02-28
CA2210891A1 (en) 1996-07-25
CN1131026C (zh) 2003-12-17
EA000276B1 (ru) 1999-02-25
CN1179100A (zh) 1998-04-15
ATE190483T1 (de) 2000-04-15
UY25774A1 (es) 2000-10-31
AU4453496A (en) 1996-08-07
UY25778A1 (es) 2000-08-21
GEP20022752B (en) 2002-08-26
CN1494898A (zh) 2004-05-12
DE69607146D1 (de) 2000-04-20
TR199700657T1 (xx) 1998-02-21
IL116830A0 (en) 1996-05-14
US5879706A (en) 1999-03-09
AP9701057A0 (en) 1997-10-31
EP0806943A1 (en) 1997-11-19
FI973062L (fi) 1997-09-18
JP3350055B2 (ja) 2002-11-25
EE03336B1 (et) 2001-02-15
OA10500A (en) 2002-04-10
CZ296514B6 (cs) 2006-03-15
ZA96448B (en) 1996-08-07
CZ229297A3 (cs) 1998-02-18
NO311488B1 (no) 2001-12-03
FI973062A0 (fi) 1997-07-18
CA2210891C (en) 2009-05-19
GB9501127D0 (en) 1995-03-08
HUP9801872A2 (hu) 1999-10-28
PT806943E (pt) 2000-08-31
BG101831A (en) 1998-04-30
CN1313081C (zh) 2007-05-02
DK0806943T3 (da) 2000-07-24
DE69607146T2 (de) 2000-09-21
BR9606769A (pt) 1997-12-30
NO973327D0 (no) 1997-07-18
EP0806943B1 (en) 2000-03-15
JPH10512564A (ja) 1998-12-02
WO1996022082A1 (en) 1996-07-25
ES2145425T3 (es) 2000-07-01
FI119722B (fi) 2009-02-27
AU710823B2 (en) 1999-09-30
MX9705459A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
MY126346A (en) Valaciclovir tablets containing colloidal silicon dioxide
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
CA2061998A1 (en) Magnesium carbonate and oil tableting aid
EP0870767A4 (en:Method)
BG103714A (en) Pararacetamol-containing tablet
CA2110166A1 (en) Tableting of colestipol hydrochloride
USD372448S (en) Foot pad
USD322985S (en) Type font
USD339595S (en) Pillow block bearing housing top
MX9500231A (es) Analgesicos de 4-arilsoindol.
MX9805713A (es) Tabletas con un alto contenido de famciclovir.
USD324483S (en) Front face of a key plug
USD328238S (en) Front face of a key plug
USD325334S (en) Front face of a key plug
USD325512S (en) Front face of a key plug
EP0625641A3 (en) Use of stellite to prevent silver plateout.
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
USD327835S (en) Front face of a key plug
USD328235S (en) Front face of a key plug
USD324485S (en) Front face of a key plug
USD327627S (en) Front face of a key plug
USD327626S (en) Front face of a key plug
USD327630S (en) Front face of a key plug
USD325693S (en) Front face of a key plug
USD328237S (en) Front face of a key plug